BLUELINX HLDGS INC's ticker is BXC and the CUSIP is 09624H208. A total of 95 filers reported holding BLUELINX HLDGS INC in Q3 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,634,083 | -1.1% | 68,633 | +12.9% | 0.00% | 0.0% |
Q2 2023 | $5,699,292 | +103.5% | 60,773 | +47.5% | 0.00% | +100.0% |
Q1 2023 | $2,800,088 | +67.8% | 41,202 | +75.6% | 0.00% | 0.0% |
Q4 2022 | $1,668,596 | +13.7% | 23,465 | -0.7% | 0.00% | 0.0% |
Q3 2022 | $1,468,000 | -10.0% | 23,638 | -3.2% | 0.00% | 0.0% |
Q2 2022 | $1,632,000 | -6.9% | 24,427 | +0.2% | 0.00% | 0.0% |
Q1 2022 | $1,753,000 | -23.5% | 24,384 | +1.9% | 0.00% | 0.0% |
Q4 2021 | $2,292,000 | +101.1% | 23,933 | +2.7% | 0.00% | – |
Q3 2021 | $1,140,000 | +3.2% | 23,314 | +6.1% | 0.00% | – |
Q2 2021 | $1,105,000 | +952.4% | 21,970 | +4.5% | 0.00% | – |
Q1 2020 | $105,000 | -65.0% | 21,028 | 0.0% | 0.00% | – |
Q4 2019 | $300,000 | -55.9% | 21,028 | 0.0% | 0.00% | – |
Q3 2019 | $680,000 | +63.1% | 21,028 | 0.0% | 0.00% | – |
Q2 2019 | $417,000 | -20.7% | 21,028 | +6.6% | 0.00% | – |
Q1 2019 | $526,000 | +7.8% | 19,722 | 0.0% | 0.00% | – |
Q4 2018 | $488,000 | -16.6% | 19,722 | +6.3% | 0.00% | – |
Q3 2018 | $585,000 | -17.4% | 18,552 | -1.5% | 0.00% | -100.0% |
Q2 2018 | $708,000 | – | 18,841 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nokomis Capital, L.L.C. | 906,650 | $26,529,000 | 11.62% |
Solas Capital Management, LLC | 334,073 | $9,775,000 | 7.46% |
WEBER ALAN W | 458,649 | $13,420,000 | 4.00% |
Voss Capital, LLC | 247,414 | $7,239,000 | 3.65% |
CROWN ADVISORS MANAGEMENT, INC. | 125,000 | $3,658,000 | 2.62% |
APOGEM CAPITAL LLC | 106,206 | $3,107,000 | 2.07% |
Acuitas Investments, LLC | 99,997 | $2,926,000 | 1.90% |
GENDELL JEFFREY L | 471,015 | $13,782,000 | 1.86% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 816,442 | $23,889,000 | 1.67% |
Greenhaven Road Investment Management, L.P. | 620,000 | $18,142,000 | 1.53% |